INTRODUCTION
Defects in tryptophan metabolism have been described in a variety of diseases. However the mechanisms underlying these defects have not been clearly established. In a recent publication Altman and Greengard (1) indicated that illness characterized by altered tryptophan metabolism could be associated with induction of the liver enzyme tryptophan pyrrolase (TP). This enzyme is the initial one in the kynurenine pathway and appears to regulate the rate of tryptophan metabolism through this pathway.
In an earlier communication (2) we reported that hepatic TP activity in mice varied relative Received for publication 31 July 1967 and in revised form 30 October 1967.
to time of day. If a similar rhythmicity exists for man and if this enzyme is the major regulatory factor for tryptophan entering the kynurenine. pathway, then one might expect that the quantity of tryptophan metabolized via this pathway would vary relative to the time the amino acid was administered.
It has long been recognized that the diazo reaction of human urine is quantitatively related to the excretion of tryptophan metabolites (3) . Indeed the commonly used analytical methods for quantitation of tryptophan metabolites still employ the diazotization procedure.
In studies reported herein we have examined the urine of human subjects given tryptophan loads at various times of day and night. We have shown by an automated diazotization technique and confirmed by column chromatographic means that the metabolism of this amino acid via the kynurenine pathway is, in major part, dependent on the time of amino acid feeding, an observation compatible with circadian variation of TP in the human. Urine was collected from all subjects for a period of 6 hr after ingestion of the amino acid. In most studies the 6 hr collection was obtained as a pool; however in certain selected cases, aliquot urines were obtained at 1-2-hr intervals for a 24 hr period after administration of the amino acid.
METHODS
Experimental design. A dose-response relationship of limited range was established in one group of male volunteers relating quantity of tryptophan administered and pmoles of diazotizable metabolites excreted.
Studies designed to evaluate the diurnal rhythmicity of tryptophan tolerance were performed in another group of subjects. A standard dose of 3 g of tryptophan was given at 0300, 0600, 0900, 1200, 1500, 1800, 2100, or 2400 hr. Normal activity appropriate to time of day was encouraged. A number of subjects were studied more than once, with at least a 48 hr period between tolerance tests. Diurnal rhythmicity of glomerular filtration was excluded by calculating data in terms of endogenous creatinine (i.e. picric acid chromogen) excretion.
Analytical methods. Total urinary "diazo reactant" was determined by the automated method of Harvey and Brothers (4) . The method is a modification of that described by Bratton and Marshall (5) and consists of diazotization with Na nitrate followed by coupling with N-(1-napthyl) ethylenediamine hydrochloride. Kynurenine SO (all metabolite standards were obtained from Calbiochem) was utilized for the standard calibration curve although anthranilic acid and O-aminohippuric acid produced similar calibration curves. Indican standards produced a color intensity which was less than one-fifth that observed using equimolar concentrations of kynurenine. In contrast xanthurenic acid, kynurenic acid, 3-hydroxykynurenine, 3-hydroxyanthranilic acid, and tryptophan were tested and found to produce no color by this method.
The elution column chromatographic method of Price, Brown, and Yess (6) was utilized in urine pools obtained from tolerance tests performed at 900 and 2100 hr. Columns were prepared with Dowex 50W-X12, and elution was accomplished with increasing concentrations of HCI. By these methods indican, kynurenine, acetylkynurenine, 3-hydroxykynurenine, anthranilic acid, anthranilic glucuronide, O-aminohippuric acid, kynurenic acid, and xanthurenic acid could be quantitated individually. Recovery curves ranging from 75 to 100% were obtained consistently for all metabolites.
Creatinine determinations were performed on all urine samples by an automated picric acid method.
RESULTS
In the narrow dose range selected for study, a definite linear relationship existed between ingested 0900-hr dose of L-tryptophan and the quantity of diazotizable material excreted. Most reported studies of tryptophan tolerance have utilized doses ranging from 1 to 4 g. A dose-response study was used to establish the sensitivity of the automated method for urinary diazotization. The quantity of "diazo reactant" as measured by the AutoAnalyzer method (4) had a linear relationship to the size of tryptophan load (Fig. 1) . As a result of these studies a standard dose of 3 g of powdered L-tryptophan was selected for all subsequent tests. It should be noted that the various tryptophan metabolites differ in the time required for optimum color development in the diazotization and coupling reaction. Color development in the automated method is recorded after a relatively brief but consistent reaction time in contrast to the manual method of Price, Brown, and Yess (6) in which color development is allowed to become maximal. For this reason the total "diazo reactant" measured by the automated technique is not mathematically comparable to the sum of the individual metabolites measured by the manual method.
Urine was collected for 24 hr in three individuals after administration of 3 g of tryptophan given at 0900 hr. A similar study was performed on four individuals given tryptophan at 2100 hr. The mean excretion of "diazo reactant" substances during the 24 hr period (shown in Fig. 2 ) revealed that the peak excretion occurred 3-4 hr after oral administration of the amino acid. Values thereafter tended to fall toward basal levels. Time of administration appeared to have little influence on the length of time in which metabolites from the oral loading dose were excreted. The major quantity of "diazo reactant" excreted as a result of tryptophan administration occurred during the initial 6 hr. Based on these investigations it was elected to obtain a standard 6 hr urine collection from all individuals undergoing these tolerance studies.
The results of investigations of tryptophan tolerance performed at 3-hr intervals during the 24 hr are shown in Fig. 3 (2, 9) ; in addition, a diurnal rhythm for tyrosine transaminase recently has been observed by a number of investigators (10, 11 ). Based on these findings, it is conceivable that feeding of protein or amino acids to patients in whom dietary nitrogen must be critically regulated, i.e. those with hepatic coma or chronic renal disease, might ultimately be adjusted by the clinician to coincide with some optimum time for their utilization.
We suggest that rhythmicity of tryptophan metabolism via the kynurenine pathway in man is based upon TP rhythmicity. While this postulate might be proven by direct measurements in liver biopsy specimens taken at varying times of day and night, indirect evidence appears to support our contention.
A diurnal rhythm for TP activity that appeared to be related in time to adrenal rhythmicity has been observed in experimental animals.
Recent studies in which liver biopsies were obtained showed that TP in humans could also be induced by pharmacologic quantities of adrenal glucocorticoids (1) .
The increased excretion of tryptophan metabolites observed in this study occured at a time that was predictable, if it were assumed that human TP varies as a function of adrenal rhythmicity. For example, if peak cortisol levels occur at 0600 hr in man, one might expect peak TP activity at approximately 0900-1100 hr (12), and peak excretion of tryptophan metabolites would be expected when the amino acid was administered at 0600 and 0900 hr, if we assume some latent period for absorption and transport to metabolic sites.
Alternative explanations for rhythmicity of the kynurenine pathway must be considered. It is possible that the enzymes subsequent to TP undergo a diurnal rhythmic inhibition causing the diazotizable metabolites to accumulate rather than to be carried to their ultimate nondiazotiable end products (i.e., niacin and quinaldic acid, etc.). However this explanation would imply the extremely unlikely possibility that all tryptophan degradative enzymes distal to TP had a similar or identical rhythmic pattern. In this context Altman and Greengard (1) indicated that at times of elevated TP activity the kynurenine degradative enzymes, kynureninase, kynurenine hydroxylase, and kynurenine transaminase, become rate-limiting; While it is functionally possible to exceed the capacity of these enzymes to degrade kynurenine, the products of these enzymes as measured herein varied in the same diurnal fashion as did kynureCircadian Periodicity of Tryptophan Metabolism nine itself. The fact that the ratios of these metabolites were somewhat dissimilar may indeed suggest that enzymes subsequent to TP become ratelimiting during the period of maximal TP activity.
It is conceivable that the tryptophan absorptive or transport mechanisms in humans may have a diurnal rhythm. This possibility appeared to be excluded by the work of Michael, Drummond, Doeden, Anderson, and Good (7) who established that doses of tryptophan three to four times in excess of our own were 100% absorbed by the gastrointestinal tract.
Other considerations which cannot be proved or disproved from our studies are a functional pyridoxine deficiency and also a shunting of tryptophan to other pathways including protein biosynthesis. Both kynureninase and kynurenine transaminase are pyridoxine-dependent enzymes (8) . However the length of time required to produce pyridoxine deficiency makes this vitamin an unlikely factor in the rhythmicity of tryptophan metabolism. (14) , Pelzl (15) , and Brewing (16) reported that acute febrile diseases were associated with increased urinary excretion of diazotizable amines. Kotake and Sakata (3) noted that advanced pulmonary tuberculosis could also produce an increase in the urinary diazotizable amines. Furthermore these workers established the fact that the measured amines were tryptophan metabolites. Altman and Greengard (1) have indicated that pathologic alteration in excretion of tryptophan metabolites occur as a result of adrenocortical hyperfunction, a state which would be expected to produce induction of TP. However at least one other regulatory factor must be considered. The activity of TP may be regulated by the concentrations of its heme coenzyme (17) . Indeed studies by Feigelson and Greengard (18) show that TP is induced in rats with experimental porphyria as a consequence of an excess in heme coenzyme. Appropriately humans with porphyria have been shown to have increased excretion of tryptophan metabolites (19) .
Finally, Berry and Smythe (20) have reported that bacterial endotoxin functions as an inhibitor of TP in experimental animals. These workers suggest that survival in endotoxemia may be correlated with maintainence of normal TP activity. The mechanism in which endotoxin inhibits TP is not completely understood. As yet no studies of tryptophan metabolism have been performed in patients with Gram-negative infections.
In summary it would appear that diurnal rhythmicity of TP in human liver may be the basis for a rhythmic change in tryptophan metabolism. Further investigations into the metabolism of this amino acid should consider the marked alterations which occur simply as a function of time of day. By the same token it would appear that the relative ease with which urinary diazotizable amines may be measured will serve as a useful tool in the study of tryptophan metabolism in a large number of clinical states.
